Dermatology and Therapy (Sep 2024)
Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study
- Bernhard Korge,
- Olivier Vanhooteghem,
- Charles W. Lynde,
- Alena Machovcova,
- Marc Perrussel,
- Elisavet Lazaridou,
- Claudio Marasca,
- David Vidal Sarro,
- Ines Duenas Pousa,
- Frederik Fierens,
- Paulette Williams,
- Saori Shimizu,
- Tanja Heidbrede,
- Richard B. Warren
Affiliations
- Bernhard Korge
- Dermatology Practice Dr. Bernhard Korge
- Olivier Vanhooteghem
- Clinique Sainte-Elisabeth
- Charles W. Lynde
- Division of Dermatology, Department of Medicine, University of Toronto
- Alena Machovcova
- Department of Dermatovenerology, University Hospital Motol
- Marc Perrussel
- University Hospital of Rennes (CHU de Rennes)—Pontchaillou
- Elisavet Lazaridou
- 2nd Department of Dermatology, Aristotle University School of Medicine—Papageorgiou General Hospital
- Claudio Marasca
- Antonio Cardarelli National Hospital
- David Vidal Sarro
- University Hospital Igualada
- Ines Duenas Pousa
- UCB Pharma
- Frederik Fierens
- UCB Pharma
- Paulette Williams
- UCB Pharma
- Saori Shimizu
- UCB Pharma
- Tanja Heidbrede
- UCB Biosciences
- Richard B. Warren
- Dermatology Centre, Northern Care Alliance NHS Foundation Trust
- DOI
- https://doi.org/10.1007/s13555-024-01271-4
- Journal volume & issue
-
Vol. 14,
no. 10
pp. 2923 – 2926
Abstract
No abstracts available.